34,340
Views
260
CrossRef citations to date
0
Altmetric
Review

A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses

, ORCID Icon, , ORCID Icon & ORCID Icon
Pages 558-570 | Received 19 Feb 2020, Accepted 25 Feb 2020, Published online: 14 Mar 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (16)

Priyanka Gopi, Manisha Gurnani, Shweta Singh, Palak Sharma & Prateek Pandya. (2023) Structural aspects of SARS-CoV-2 mutations: Implications to plausible infectivity with ACE-2 using computational modeling approach. Journal of Biomolecular Structure and Dynamics 41:14, pages 6518-6533.
Read now
Lingling Lu, Jiaolong Zheng, Bang Liu, Haicong Wu, Jiaofeng Huang, Liqing Wu & Dongliang Li. (2022) The m7G Modification Level and Immune Infiltration Characteristics in Patients with COVID-19. Journal of Multidisciplinary Healthcare 15, pages 2461-2472.
Read now
Samaneh Jafari Porzani, Ozcan Konur & Bahareh Nowruzi. (2022) Cyanobacterial natural products as sources for antiviral drug discovery against COVID-19. Journal of Biomolecular Structure and Dynamics 40:16, pages 7629-7644.
Read now
Nilkanta Chowdhury & Angshuman Bagchi. (2022) Identification of the binding interactions of some novel antiviral compounds against Nsp1 protein from SARS-CoV-2 (COVID-19) through high throughput screening. Journal of Biomolecular Structure and Dynamics 40:14, pages 6634-6641.
Read now
Sreus A. G. Naidu, Roger A. Clemens, Peter Pressman, Mehreen Zaigham, Kamran Kadkhoda, Kelvin J. A. Davies & A. Satyanarayan Naidu. (2022) COVID-19 during Pregnancy and Postpartum:. Journal of Dietary Supplements 19:1, pages 115-142.
Read now
Muhammad Jamal, Hina Iqbal Bangash, Maria Habiba, Yufei Lei, Tian Xie, Jiaxing Sun, Zimeng Wei, Zixi Hong, Liang Shao & Qiuping Zhang. (2021) Immune dysregulation and system pathology in COVID-19. Virulence 12:1, pages 918-936.
Read now
Anindita Banerjee, Upasana Ganguly, Sarama Saha, Suddhachitta Chakrabarti, Reena V Saini, Ravindra K Rawal, Luciano Saso & Sasanka Chakrabarti. (2021) Vitamin D and immuno-pathology of COVID-19: many interactions but uncertain therapeutic benefits. Expert Review of Anti-infective Therapy 19:10, pages 1245-1258.
Read now
Lidong Wang & Cheryl Ann Alexander. (2021) COVID-19: a pandemic challenging healthcare systems. IISE Transactions on Healthcare Systems Engineering 11:4, pages 271-292.
Read now
Norma Saad & Salim Moussa. (2021) Immune response to COVID-19 infection: a double-edged sword. Immunological Medicine 44:3, pages 187-196.
Read now
Mohammad Mahdi Nejadi Babadaei, Anwarul Hasan, Yasaman Vahdani, Samir Haj Bloukh, Majid Sharifi, Ehsan Kachooei, Setareh Haghighat & Mojtaba Falahati. (2021) Development of remdesivir repositioning as a nucleotide analog against COVID-19 RNA dependent RNA polymerase. Journal of Biomolecular Structure and Dynamics 39:10, pages 3771-3779.
Read now
Nicholas Hartog, William Faber, Austin Frisch, Jacob Bauss, Caleb P Bupp, Surender Rajasekaran & Jeremy W Prokop. (2021) SARS-CoV-2 infection: molecular mechanisms of severe outcomes to suggest therapeutics. Expert Review of Proteomics 18:2, pages 105-118.
Read now
Zi-Wei Ye, Shuofeng Yuan, Jasper Fuk-Woo Chan, Anna Jinxia Zhang, Ching-Yun Yu, Chon Phin Ong, Dong Yang, Chris Chun-Yiu Chan, Kaiming Tang, Jianli Cao, Vincent Kwok-Man Poon, Chris Chung-Sing Chan, Jian-Piao Cai, Hin Chu, Kwok-Yung Yuen & Dong-Yan Jin. (2021) Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection. Emerging Microbes & Infections 10:1, pages 291-304.
Read now
Pierpaolo Di Micco, Gianluca Di Micco, Vincenzo Russo, Maria Rita Poggiano, Ciro Salzano, Marijan Bosevski, Michele Imparato, Luca Fontanella & Andrea Fontanella. (2020) Blood Targets of Adjuvant Drugs Against COVID19. Journal of Blood Medicine 11, pages 237-241.
Read now
Afsane Bahrami & Gordon A Ferns. (2020) Genetic and Pathogenic Characterization of SARS-CoV-2: A Review. Future Virology 15:8, pages 533-549.
Read now
Xiao-Yu Zhang, Lin Zhang, Yang Zhao & Liang Chen. (2020) Risk Assessment and Prediction of Severe or Critical COVID-19 Illness in Older Adults. Clinical Interventions in Aging 15, pages 2145-2153.
Read now
Khalid Munir, Shoaib Ashraf, Isra Munir, Hamna Khalid, Mohammad Akram Muneer, Noreen Mukhtar, Shahid Amin, Sohaib Ashraf, Muhammad Ahmad Imran, Umer Chaudhry, Muhammad Usman Zaheer, Maria Arshad, Rukhsana Munir, Ali Ahmad & Xin Zhao. (2020) Zoonotic and reverse zoonotic events of SARS-CoV-2 and their impact on global health. Emerging Microbes & Infections 9:1, pages 2222-2235.
Read now

Articles from other publishers (244)

Caterina Lonati, Georgy Berezhnoy, Nathan Lawler, Reika Masuda, Aditi Kulkarni, Samuele Sala, Philipp Nitschke, Laimdota Zizmare, Daniele Bucci, Claire Cannet, Hartmut Schäfer, Yogesh Singh, Nicola Gray, Samantha Lodge, Jeremy Nicholson, Uta Merle, Julien Wist & Christoph Trautwein. (2024) Urinary phenotyping of SARS-CoV-2 infection connects clinical diagnostics with metabolomics and uncovers impaired NAD + pathway and SIRT1 activation . Clinical Chemistry and Laboratory Medicine (CCLM) 62:4, pages 770-788.
Crossref
Zahra Sefatjoo, Seyed Reza Mohebbi, Seyed Masoud Hosseini, Shahrzad Shoraka, Mahsa Saeedi Niasar, Kaveh Baghaei, Anna Meyfour, Amir Sadeghi, Habib Malekpour, Hamid Asadzadeh Aghdaei & Mohammad Reza Zali. (2024) Evaluation of long non-coding RNAs EGOT, NRAV, NRIR and mRNAs ISG15 and IFITM3 expressions in COVID-19 patients. Cytokine 175, pages 156495.
Crossref
Yu Chen, Shanshan Zhu, Tianxing Liao, Chunxuan Wang, Jiajun Han, Zhenyu Yang, Xiaolong Lu, Zenglei Hu, Jiao Hu, Xiaoquan Wang, Min Gu, Ruyi Gao, Kaituo Liu, Xiaowen Liu, Chan Ding, Shunlin Hu & Xiufan Liu. (2024) The HN protein of Newcastle disease virus induces cell apoptosis through the induction of lysosomal membrane permeabilization. PLOS Pathogens 20:2, pages e1011981.
Crossref
Geir Bjørklund, Roman Lysiuk, Yuliya Semenova, Larysa Lenchyk, Natalia Dub, Monica Daniela Doşa & Tony Hangan. (2024) Herbal Substances with Antiviral Effects: Features and Prospects for the Treatment of Viral Diseases with Emphasis on Pro-Inflammatory Cytokines. Current Medicinal Chemistry 31:4, pages 393-409.
Crossref
Debashis Dutta, Jianuo Liu & Huangui Xiong. 2024. HIV-Associated Neurocognitive Disorders. HIV-Associated Neurocognitive Disorders 355 378 .
Vanyo Mitev. (2023) Comparison of treatment of COVID-19 with inhaled bromhexine, higher doses of colchicine and hymecromone with WHO-recommended paxlovid, molnupiravir, remdesivir, anti-IL-6 receptor antibodies and baricitinib. Pharmacia 70:4, pages 1177-1193.
Crossref
Qiwei Hong, Xinyue Shang, Yanan Wu, Zhenlin Nie & Bangshun He. (2023) Potential Targets and Mechanisms of Bitter Almond-Licorice for COVID-19 Treatment Based on Network Pharmacology and Molecular Docking. Current Pharmaceutical Design 29:33, pages 2655-2667.
Crossref
Manimani Riziki Ghislain, Willy Tambwe Muzumbukilwa & Nombulelo Magula. (2023) Risk factors for death in hospitalized COVID-19 patients in Africa: A systematic review and meta-analysis. Medicine 102:35, pages e34405.
Crossref
Gianmarco Marcianò, Lucia Muraca, Vincenzo Rania & Luca Gallelli. (2023) Ibuprofen in the Management of Viral Infections: The Lesson of COVID‐19 for Its Use in a Clinical Setting. The Journal of Clinical Pharmacology 63:9, pages 975-992.
Crossref
Marina M. Ziganshina, Nadezhda V. Shilova, Eugenia O. Khalturina, Natalya V. Dolgushina, Sergey V. Borisevich, Ekaterina L. Yarotskaya, Nicolai V. Bovin & Gennady T. Sukhikh. (2023) Antibody-Dependent Enhancement with a Focus on SARS-CoV-2 and Anti-Glycan Antibodies. Viruses 15:7, pages 1584.
Crossref
Marina Shkolnikova, Elena Averyanova & Evgeny Rozhnov. (2023) Micronutrients Role in the Proinflammatory Cytokine Gene Expression Regulation in COVID-19 and Post-COVID-19 Syndromes. Food Industry 8:2, pages 116-129.
Crossref
Esmaeel Sharifi, Satar Yousefiasl, Maria Trovato, Rossella Sartorius, Yasaman Esmaeili, Hamid Goodarzi, Matineh Ghomi, Ashkan Bigham, Farnaz Dabbagh Moghaddam, Maryam Heidarifard, Samiramis Pourmotabed, Ehsan Nazarzadeh Zare, Ana Cláudia Paiva-Santos, Navid Rabiee, Xiangdong Wang & Franklin R. Tay. (2023) Nanostructures for prevention, diagnosis, and treatment of viral respiratory infections: from influenza virus to SARS-CoV-2 variants. Journal of Nanobiotechnology 21:1.
Crossref
V. S. Lekshmi, Kumari Asha, Melvin Sanicas, Abhila Asi, U. M. Arya & Binod Kumar. (2023) PI3K/Akt/Nrf2 mediated cellular signaling and virus-host interactions: latest updates on the potential therapeutic management of SARS-CoV-2 infection. Frontiers in Molecular Biosciences 10.
Crossref
Mst. Mahfuza RahmanKouser Md.Uthpall Kumar RoyShahriar Mohammad ShohanJarin TasnimMd. Jahirul IslamMst. Shagorika ShilaSangita ChakrabortyMir Imam Ibne Wahed. (2023) The Significance and Implications of Nanotechnology in COVID-19. Research Journal of Pharmacy and Technology, pages 2499-2506.
Crossref
Debashis Dutta, Jianuo Liu & Huangui Xiong. (2023) The Impact of COVID-19 on People Living with HIV-1 and HIV-1-Associated Neurological Complications. Viruses 15:5, pages 1117.
Crossref
Tsung-Hsien Chen, Chia-Jung Chang & Peir-Haur Hung. (2023) Possible Pathogenesis and Prevention of Long COVID: SARS-CoV-2-Induced Mitochondrial Disorder. International Journal of Molecular Sciences 24:9, pages 8034.
Crossref
D. Çekiç, A. B. Genc, S. Yaylacı, H. Dheir, A. C. Genc, İ. Yıldırım, H. Kocayigit, F. B. Tuncer, H. Toptan, E. Çokluk, B. E. Demiryurek, A. Nalbant, T. Kaya, A. Tamer & O. Karabay. (2023) Is there an association between mIDkIne levels and the prognosis of COVID-19 disease?. Messenger of ANESTHESIOLOGY AND RESUSCITATION 20:2, pages 73-77.
Crossref
A. A. Inyutkina, V. P. Nikulina & M. A. Godkov. (2023) Features of the Immune Response in COVID-19. Russian Sklifosovsky Journal "Emergency Medical Care" 12:1, pages 122-129.
Crossref
Mina Ghofrani NezhadGiti JamiOmid KooshkakiSajjad Chamani & Ali Naghizadeh. (2023) The Role of Inflammatory Cytokines (Interleukin-1 and Interleukin-6) as a Potential Biomarker in the Different Stages of COVID-19 (Mild, Severe, and Critical) . Journal of Interferon & Cytokine Research 43:4, pages 147-163.
Crossref
Marcos I. Restrepo, Judith Marin-Corral, Juan J. Rodriguez, Valeria Restrepo & Rodrigo Cavallazzi. (2023) Cardiovascular Complications in Coronavirus Disease 2019—Pathogenesis and Management. Seminars in Respiratory and Critical Care Medicine 44:01, pages 021-034.
Crossref
José Rivera-Torres, Natalia Girón & Esther San José. (2023) COVID-19: A Comprehensive Review on Cardiovascular Alterations, Immunity, and Therapeutics in Older Adults. Journal of Clinical Medicine 12:2, pages 488.
Crossref
HendHashem Mahmoud, MohamedA Tageldin & YehiaR Yousef. (2023) Proportion and prognosis of ICU-admitted coronavirus disease 2019-infected patients in relation to all hospitalized cases in Abbasia Chest Hospital, Cairo. The Egyptian Journal of Chest Diseases and Tuberculosis 72:3, pages 358.
Crossref
Narges Chamkouri, Forouzan Absalan, Zahra Koolivand & Mahsa Yousefi. (2023) Nonsteroidal anti-inflammatory drugs in viral infections disease, specially COVID-19. Advanced Biomedical Research 12:1, pages 20.
Crossref
Rodrigo Núñez-Cortés, Rubén López-Bueno, Rodrigo Torres-Castro, Camilo Soto-Carmona, Maritza Ortega-Palavecinos, SofÍa Pérez-Alenda, Lilian Solis-Navarro, óscar DÍaz-Cambronero, Francisco M. Martinez-Arnau & JoaquÍn Calatayud. (2023) Risk Factors for One-Year Mortality in Hospitalized Adults with Severe COVID-19. Aging and disease 14:1, pages 14.
Crossref
Nathaniel Chapin & Rwik Sen. 2023. Omics approaches and technologies in COVID-19. Omics approaches and technologies in COVID-19 191 218 .
Mustafa TOSUN & Hasan ÖLMEZ. (2022) Effect of Tocilizumab Use on Mortality in COVID-19 Patients Admitted to Intensive Care UnitYoğun Bakım Ünitesine Kabul Edilen COVID-19 Hastalarında Tocilizumab Kullanımının Mortalite Üzerine Etkisi. Düzce Tıp Fakültesi Dergisi 24:3, pages 227-234.
Crossref
Sibei Lei, Xiaohua Chen, Jieping Wu, Xingmei Duan & Ke Men. (2022) Small molecules in the treatment of COVID-19. Signal Transduction and Targeted Therapy 7:1.
Crossref
Omid Gholizadeh, Saman Yasamineh, Parya Amini, Hamed Afkhami, Abbasali Delarampour, Sama Akbarzadeh, Rasool Karimi Matloub, Mahlagha Zahedi, Parastoo Hosseini, Mehrnaz Hajiesmaeili & Vahdat Poortahmasebi. (2022) Therapeutic and diagnostic applications of nanoparticles in the management of COVID-19: a comprehensive overview. Virology Journal 19:1.
Crossref
Wamankar Suchita, Sahu Tilotma, Shrivastava Saurabh, Kumar Abhishek, Sahu Sagar & Kumar Lokesh. (2022) Molecular Elucidation and Therapeutic Targeting for Combating COVID-19: Current Scenario and Future Prospective. Current Molecular Medicine 22:10, pages 894-907.
Crossref
Xiangyu Wang, Yuan Li, Taiyu Ban, Jiarun Zhu, Lyuzhou Chen, Muhammad Usman, Xin Wang, Huanhuan Chen, Xiaomei Chen, Cyril Leung & Chunyan Miao. (2022) Dynamic Link Prediction for Discovery of New Impactful COVID-19 Research Approaches. IEEE Journal of Biomedical and Health Informatics 26:12, pages 5883-5894.
Crossref
Lingling Lu, Yijing Li, Xiulan Ao, Jiaofeng Huang, Bang Liu, Liqing Wu & Dongliang Li. (2022) The risk of COVID-19 can be predicted by a nomogram based on m6A-related genes. Infection, Genetics and Evolution 106, pages 105389.
Crossref
Xiaojun Gao, Dan Fang, Yu Liang, Xin Deng, Ni Chen, Min Zeng & Mao Luo. (2022) Circular RNAs as emerging regulators in COVID-19 pathogenesis and progression. Frontiers in Immunology 13.
Crossref
Yuan-Yuan Yong, Li Zhang, Yu-Jiao Hu, Jian-Ming Wu, Lu Yan, Yi-Ru Pan, Yong Tang, Lu Yu, Betty Yuen-Kwan Law, Chong-Lin Yu, Jie Zhou, Mao Li, Da-Lian Qin, Xiao-Gang Zhou & An-Guo Wu. (2022) Targeting autophagy regulation in NLRP3 inflammasome-mediated lung inflammation in COVID-19. Clinical Immunology 244, pages 109093.
Crossref
Srividhya Venkataraman. (2022) Plant Molecular Pharming and Plant-Derived Compounds towards Generation of Vaccines and Therapeutics against Coronaviruses. Vaccines 10:11, pages 1805.
Crossref
Guy Henri Hans, Davina Wildemeersch & Ine Meeus. (2022) Integrated Analgesic Care in the Current Human Monkeypox Outbreak: Perspectives on an Integrated and Holistic Approach Combining Old Allies with Innovative Technologies. Medicina 58:10, pages 1454.
Crossref
Mubarak Muhammad, Tasneem M. Hassan, Sani S. Baba, Mustapha I. Radda, Mubarak M. Mutawakkil, Majida A. Musa, Sazaly AbuBakar, Shih Keng Loong & Ibrahim Yusuf. (2022) Exploring NFkB pathway as a potent strategy to mitigate COVID-19 severe morbidity and mortality. Journal of Public Health in Africa 13:3.
Crossref
Faulinda Ely Nastiti, Shahrulniza Musa, Eiad Yafi & Ritu Chauhan. (2022) Systematic Literature Review: Machine Learning Prediction Model for Covid-19 Spreading. Systematic Literature Review: Machine Learning Prediction Model for Covid-19 Spreading.
Lijuan Xiong, Qian Li, Xiongjing Cao, Huangguo Xiong, Ming Huang, Fengwen Yang, Daquan Meng, Mei Zhou, Yanzhao Zhang, Yunzhou Fan, Liang Tang, Yang Jin, Jiahong Xia & Yu Hu. (2022) Recovery of functional fitness, lung function, and immune function in healthcare workers with nonsevere and severe COVID-19 at 13 months after discharge from the hospital: a prospective cohort study. International Journal of Infectious Diseases 123, pages 119-126.
Crossref
Swati Chaudhary, Mohan Kumar & Mahima Kaushik. (2022) Interface of G-quadruplex with both stabilizing and destabilizing ligands for targeting various diseases. International Journal of Biological Macromolecules 219, pages 414-427.
Crossref
Mohammad Islamuddin, Salman Ahmad Mustfa, Shehla Nasar Mir Najib Ullah, Usmaan Omer, Kentaro Kato & Shama Parveen. (2022) Innate Immune Response and Inflammasome Activation During SARS-CoV-2 Infection. Inflammation 45:5, pages 1849-1863.
Crossref
Pallavi R Bhakaney, Rashmi R Walke, Chaitanya A Kulkarni & Vishnu Vardhan. (2022) Immediate Effectiveness of Chest Proprioceptive Neuromuscular Facilitation (PNF) Technique on Hemodynamic Status in COVID-19 Patients: An Original Research. Cureus.
Crossref
P. V. MAZIN, R. K. KHAFISIANOVA, V. P. MAZIN, A. A. GALKIN & A. K. OSKANOV. (2022) Cycloferon as a Means for Prevention, Treatment, and Control of COVID-19: Multidisciplinary and Comparative Historical Aspects. Antibiotics and Chemotherapy 67:5-6, pages 61-69.
Crossref
Kapil Kumar Malviya. (2022) SARS-CoV-2 infection: Pathogenesis, Immune Responses, Diagnosis. Journal of Pure and Applied Microbiology 16:3, pages 1425-1440.
Crossref
Daniel Adesse, Luis Gladulich, Liandra Alvarez-Rosa, Michele Siqueira, Anne Caroline Marcos, Marialice Heider, Caroline Soares Motta, Silvia Torices, Michal Toborek & Joice Stipursky. (2022) Role of aging in Blood–Brain Barrier dysfunction and susceptibility to SARS-CoV-2 infection: impacts on neurological symptoms of COVID-19. Fluids and Barriers of the CNS 19:1.
Crossref
Melania Scarcella, Danila d’Angelo, Mariangela Ciampa, Simona Tafuri, Luigi Avallone, Luigi Michele Pavone & Valeria De Pasquale. (2022) The Key Role of Lysosomal Protease Cathepsins in Viral Infections. International Journal of Molecular Sciences 23:16, pages 9089.
Crossref
Kunal R Chandekar, Swayamjeet Satapathy, Harmandeep Singh & Anish Bhattacharya. (2022) Molecular imaging as a tool for evaluation of COVID-19 sequelae – A review of literature. World Journal of Radiology 14:7, pages 194-208.
Crossref
Loredana Raciti, Rosaria De Luca, Gianfranco Raciti, Francesca Antonia Arcadi & Rocco Salvatore Calabrò. (2022) The Use of Palmitoylethanolamide in the Treatment of Long COVID: A Real-Life Retrospective Cohort Study. Medical Sciences 10:3, pages 37.
Crossref
Dorota Kamińska, Dominika Dęborska-Materkowska, Katarzyna Kościelska-Kasprzak, Oktawia Mazanowska, Agata Remiorz, Paweł Poznański, Magdalena Durlik & Magdalena Krajewska. (2022) Immunity after COVID-19 Recovery and Vaccination: Similarities and Differences. Vaccines 10:7, pages 1068.
Crossref
Sergey G. Sсherbak, Dmitry A. Vologzhanin, Aleksandr S. Golota, Tatyana A. Kamilova & Stanislav V. Makarenko. (2022) Cellular immunity in patients with COVID-19: molecular biology, pathophysiology, and clinical implications. Journal of Clinical Practice 13:2, pages 66-87.
Crossref
Prachi Singh, Shruthi S. Bhat, Ardra Punnapuzha, Amrutha Bhagavatula, Babu U. Venkanna, Rafiq Mohamed & Raghavendra P. Rao. (2022) Effect of Key Phytochemicals from Andrographis paniculata, Tinospora cordifolia, and Ocimum sanctum on PLpro-ISG15 De-Conjugation Machinery—A Computational Approach. Computation 10:7, pages 109.
Crossref
Geir Bjorklund, Roman Lysiuk, Monica Butnariu, Larysa Lenchyk, Vineet Sharma, Rohit Sharma & Natalia Martins. (2022) LOW PREVALENCE OF COVID-19 IN LAOS AND CAMBODIA: DOES DIET PLAY A ROLE?. Acta Medica Leopoliensia 28:1-2, pages 161-180.
Crossref
Caroline Junqueira, Ângela Crespo, Shahin Ranjbar, Luna B. de Lacerda, Mercedes Lewandrowski, Jacob Ingber, Blair Parry, Sagi Ravid, Sarah Clark, Marie Rose Schrimpf, Felicia Ho, Caroline Beakes, Justin Margolin, Nicole Russell, Kyle Kays, Julie Boucau, Upasana Das Adhikari, Setu M. Vora, Valerie Leger, Lee Gehrke, Lauren A. Henderson, Erin Janssen, Douglas Kwon, Chris Sander, Jonathan Abraham, Marcia B. Goldberg, Hao Wu, Gautam Mehta, Steven Bell, Anne E. Goldfeld, Michael R. Filbin & Judy Lieberman. (2022) FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation. Nature 606:7914, pages 576-584.
Crossref
Alejandra Romero-Morán, Anai Zavala-Franco, José L. Sánchez-Salas, Miguel Ángel Méndez-Rojas & Joel Molina-Reyes. (2022) Electrostatically charged rutile TiO2 surfaces with enhanced photocatalytic activity for bacteria inactivation. Catalysis Today 392-393, pages 154-166.
Crossref
Zhoujie Zhu, Jiayi Shi, Long Li, Jinling Wang, Yufen Zhao & Huabin Ma. (2022) Therapy Targets SARS-CoV-2 Infection-Induced Cell Death. Frontiers in Immunology 13.
Crossref
AISHWARYA S. PATIL, RANI PURI & B. S. WAKURE. (2022) A REVIEW ON LACTOFERRIN PRINCIPLE CONSTITUENT OF BOVINE COLOSTRUM: IN COVID19. International Journal of Current Pharmaceutical Research, pages 1-8.
Crossref
Elizabeth R. Vanderwall, Kaitlyn A. Barrow, Lucille M. Rich, David F. Read, Cole Trapnell, Oghenemega Okoloko, Steven F. Ziegler, Teal S. Hallstrand, Maria P. White & Jason S. Debley. (2022) Airway epithelial interferon response to SARS-CoV-2 is inferior to rhinovirus and heterologous rhinovirus infection suppresses SARS-CoV-2 replication. Scientific Reports 12:1.
Crossref
Colin Day, Carson Studders, Kim Arklie, Asees Kaur, Kyra Teetzen, Rebecca Kirsch, Laila Abelseth, Ian Fraser, Emily Abelseth & Stephanie M. Willerth. (2022) The effect of SARS-CoV-2 on the nervous system: a review of neurological impacts caused by human coronaviruses. Reviews in the Neurosciences 33:3, pages 257-268.
Crossref
Paulina Niedźwiedzka-Rystwej, Adam Majchrzak, Sara Kurkowska, Paulina Małkowska, Olga Sierawska, Rafał Hrynkiewicz & Miłosz Parczewski. (2022) Immune Signature of COVID-19: In-Depth Reasons and Consequences of the Cytokine Storm. International Journal of Molecular Sciences 23:9, pages 4545.
Crossref
Chi-Ping Chan & Dong-Yan Jin. (2022) Cytoplasmic RNA sensors and their interplay with RNA-binding partners in innate antiviral response: theme and variations. RNA 28:4, pages 449-477.
Crossref
Stefanie M. Bader, James P. Cooney, Marc Pellegrini & Marcel Doerflinger. (2022) Programmed cell death: the pathways to severe COVID-19?. Biochemical Journal 479:5, pages 609-628.
Crossref
Chantal Barksdale, Franciele C. Kipper, Shreya Tripathy, Selvakumar Subbian, Charles N. Serhan & Dipak Panigrahy. (2022) COVID-19 and cancer: start the resolution!. Cancer and Metastasis Reviews 41:1, pages 1-15.
Crossref
Qin Ning, Di Wu, Xiaojing Wang, Dong Xi, Tao Chen, Guang Chen, Hongwu Wang, Huiling Lu, Ming Wang, Lin Zhu, Junjian Hu, Tingting Liu, Ke Ma, Meifang Han & Xiaoping Luo. (2022) The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication. Signal Transduction and Targeted Therapy 7:1.
Crossref
Bharath Kumar Gajjela & Ming-Ming Zhou. (2022) Calming the cytokine storm of COVID-19 through inhibition of JAK2/STAT3 signaling. Drug Discovery Today 27:2, pages 390-400.
Crossref
M. du Plessis, C. Fourie, J. Riedemann, W.J.S. de Villiers & A.M. Engelbrecht. (2022) Cancer and Covid-19: Collectively catastrophic. Cytokine & Growth Factor Reviews 63, pages 78-89.
Crossref
Behrouz Shademan, Alireza Nourazarian, Saba Hajazimian, Alireza Isazadeh, Cigir Biray Avci & Mahin Ahangar Oskouee. (2022) CRISPR Technology in Gene-Editing-Based Detection and Treatment of SARS-CoV-2. Frontiers in Molecular Biosciences 8.
Crossref
Muhammad M. AbdelGhaffar, Dalia Omran, Ahmed Elgebaly, Eshak I. Bahbah, Shimaa Afify, Mohamed AlSoda, Mohamed El-Shiekh, Enass S. ElSayed, Soha S. Shaaban, Samah AbdelHafez, Khaled Elkelany, Ayman A. Eltayar, Omnia S. Ali, Lamiaa Kamal, Ahmed M. Heiba, Ahmad El Askary & Hend Ibrahim Shousha. (2022) Prediction of mortality in hospitalized Egyptian patients with Coronavirus disease-2019: A multicenter retrospective study. PLOS ONE 17:1, pages e0262348.
Crossref
Ruby A. Escobedo, Deepak Kaushal & Dhiraj K. Singh. (2022) Insights Into the Changing Landscape of Coronavirus Disease 2019. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Priyal Mistry, Fatima Barmania, Juanita Mellet, Kimberly Peta, Adéle Strydom, Ignatius M. Viljoen, William James, Siamon Gordon & Michael S. Pepper. (2022) SARS-CoV-2 Variants, Vaccines, and Host Immunity. Frontiers in Immunology 12.
Crossref
Nada Banjac, Ilija Ramić, Snježana Đokić, Tijana Pejić, Igor Korać, Đorđe Stojisavljević & Nevena Todorović. (2022) COVID-19 in the Emergency Department of the Primary Healthcare Centre Banja Luka. Scripta Medica 53:1, pages 21-28.
Crossref
SaurabhPratap Singh, Pratyush Singh, OmPrakash Gupta & Shalini Gupta. (2022) Coronavirus disease: Dental review. Journal of Oral and Maxillofacial Pathology 26:1, pages 16.
Crossref
Moulay Abdelmonaim El Hidan, Soraia El Baz, Mohamed Merzouki, Kholoud Kahime, Moulay Abdeljalil Ait Baamrane, Mohammed Rhazi, Ahmed Draoui, Mustapha Agnaou, Mohamed Ait Hamza, Aissam El Finti, Abdelaziz Zahidi & Abdelhamid El Mousadik. 2022. Public Health and Economic Resiliency in the Post-COVID-19 Era. Public Health and Economic Resiliency in the Post-COVID-19 Era 1 20 .
MM Samim, Debjyoti Dhar, Sheetal GoyalTreshita Dey, Naznin Parvin, Rutul D. Shah, Vikram Singh, Sampurna Chowdhury, Bhavesh Mohan Lal, Nibu Varghese, Abhishek Gohel, Abhishek Chowdhury, Aritra Chatterjee & Shahyan Siddiqui. (2022) AI-CoV Study: Autoimmune Encephalitis Associated With COVID-19 and Its Vaccines—A Systematic Review. Journal of Clinical Neurology 18:6, pages 692.
Crossref
Hamid Chegni, Hadise Babaii, Zuhair M Hassan & Manoochehr Pourshaban. (2022) Immune response and cytokine storm in SARS-CoV-2 infection: Risk factors, ways of control and treatment. European Journal of Inflammation 20, pages 1721727X2210989.
Crossref
N. V. Goncharov, K. A. Vasilyev, I. V. Kudryavtsev, P. P. Avdonin, D. A. Belinskaia, M. A. Stukova, O. V. Shamova & P. V. Avdonin. (2022) Experimental Search for New Means of Pathogenetic Therapy COVID-19: Inhibitor of H2-Receptors Famotidine Increases the Effect of Oseltamivir on Survival and Immune Status of Mice Infected by A/PR/8/34 (H1N1). Journal of Evolutionary Biochemistry and Physiology 58:1, pages 230-246.
Crossref
Abdelmohcine Aimrane, Mehdi Ait Laaradia, Denis Sereno, Pascale Perrin, Ahmed Draoui, Blaid Bougadir, Mohamed Hadach, Mustapha Zahir, Naima Fdil, Omar El Hiba, Moulay Abdelmonaim El Hidan & Kholoud Kahime. (2022) Insight into COVID-19's epidemiology, pathology, and treatment. Heliyon 8:1, pages e08799.
Crossref
L. Cedillo-Barrón, J. García-Cordero, N.J. Mendoza-Ramírez & S.P. Martínez-Frías. 2022. Biomedical Innovations to Combat COVID-19. Biomedical Innovations to Combat COVID-19 95 113 .
Joseph Bamidele Awotunde, Rasheed Gbenga Jimoh, Opeyemi Emmanuel Matiluko, Babatunde Gbadamosi & Gbemisola Janet Ajamu. 2022. Intelligent Interactive Multimedia Systems for e-Healthcare Applications. Intelligent Interactive Multimedia Systems for e-Healthcare Applications 191 214 .
Umair MallickUmair Mallick. 2022. Cardiovascular Complications of COVID-19. Cardiovascular Complications of COVID-19 217 242 .
Roseline Oluwaseun Ogundokun, Joseph Bamidele Awotunde, Emmanuel Abidemi Adeniyi & Sanjay Misra. 2022. Intelligent Internet of Things for Healthcare and Industry. Intelligent Internet of Things for Healthcare and Industry 83 103 .
Juha Kaivola, Tuula Anneli Nyman & Sampsa Matikainen. (2021) Inflammasomes and SARS-CoV-2 Infection. Viruses 13:12, pages 2513.
Crossref
Rittibet Yapasert, Patompong Khaw-on & Ratana Banjerdpongchai. (2021) Coronavirus Infection-Associated Cell Death Signaling and Potential Therapeutic Targets. Molecules 26:24, pages 7459.
Crossref
Han Eol Jeong, Hyesung Lee, Hyun Joon Shin, Young June Choe, Kristian B Filion & Ju-Young Shin. (2021) Association Between Nonsteroidal Antiinflammatory Drug Use and Adverse Clinical Outcomes Among Adults Hospitalized With Coronavirus 2019 in South Korea: A Nationwide Study. Clinical Infectious Diseases 73:11, pages e4179-e4188.
Crossref
Darshan Devang Divakar, Shruti Basavaraj Nimbeni, Abdulaziz A. Al-Kheraif, Aftab Ahmed Khan, Sachin Naik, Sanjeev Balappa Khanagar, Chitra Jhugroo & Basavaraj Nimbeni. (2021) Knowledge and attitude of dental professionals toward COVID-19 in Riyadh, Saudi Arabia: a cross-sectional survey. Asian Biomedicine 15:6, pages 277-284.
Crossref
Javier Pamplona, Rubén Solano, Cristina Soler & Miriam Sabat. (2020) Epidemiological approximation of the enteric manifestation and possible fecal–oral transmission in COVID-19: a preliminary systematic review. European Journal of Gastroenterology & Hepatology 33:12, pages e21-e29.
Crossref
Amirhossein MardiSepideh MeidaninikjehSepideh NikfarjamNaime Majidi ZolbaninReza Jafari. (2021) Interleukin-1 in COVID-19 Infection: Immunopathogenesis and Possible Therapeutic Perspective . Viral Immunology 34:10, pages 679-688.
Crossref
Hasnat Khan, Shivangi Patel & Anuradha Majumdar. (2021) Role of NRF2 and Sirtuin activators in COVID-19. Clinical Immunology 233, pages 108879.
Crossref
Ravinder Singh, Hamed Hemati, Meenu Bajpai, Pushpa Yadav, Ashish Maheshwari, Suresh Kumar, Sonal Agrawal, Jayesh Kumar Sevak, Mojahidul Islam, Jaswinder Singh Mars, Shiv K Sarin & Nirupama Trehanpati. (2021) Sustained expression of inflammatory monocytes and activated T cells in COVID‐19 patients and recovered convalescent plasma donors. Immunity, Inflammation and Disease 9:4, pages 1279-1290.
Crossref
Chinmay Saha, Sayantan Laha, Raghunath Chatterjee & Nitai P. Bhattacharyya. (2021) Co-Regulation of Protein Coding Genes by Transcription Factor and Long Non-Coding RNA in SARS-CoV-2 Infected Cells: An In Silico Analysis. Non-Coding RNA 7:4, pages 74.
Crossref
Kiran Iqbal Masood, Maliha Yameen, Javeria Ashraf, Saba Shahid, Syed Faisal Mahmood, Asghar Nasir, Nosheen Nasir, Bushra Jamil, Najia Karim Ghanchi, Iffat Khanum, Safina Abdul Razzak, Akbar Kanji, Rabia Hussain, Martin E. Rottenberg & Zahra Hasan. (2021) Upregulated type I interferon responses in asymptomatic COVID-19 infection are associated with improved clinical outcome. Scientific Reports 11:1.
Crossref
A. Yu. Perevaryukha. (2022) Simulation of Scenarios of a Deep Population Crisis in a Rapidly Growing Population. Biophysics 66:6, pages 974-991.
Crossref
Sarvin Sanaie, Elham Golipour, Ali Shamekh, Mohammad Reza Sadaie, Ata Mahmoodpoor & Mehdi Yousefi. (2021) Immune response variables and viral mutations impact on COVID-19 reinfection and relapse. International Immunopharmacology 100, pages 108108.
Crossref
Hengyu Liu, Wenhao Zhong, Xinyu Zhang, Dongjun Lin & Jun Wu. (2021) Nanomedicine as a promising strategy for the theranostics of infectious diseases. Journal of Materials Chemistry B 9:38, pages 7878-7908.
Crossref
Shahab Mahmoudvand & Somayeh Shokri. (2021) Interactions between SARS coronavirus 2 papain‐like protease and immune system: A potential drug target for the treatment of COVID‐19. Scandinavian Journal of Immunology 94:4.
Crossref
Marco Matucci-Cerinic, Michael Hughes, Gloria Taliani & Bashar Kahaleh. (2021) Similarities between COVID-19 and systemic sclerosis early vasculopathy: A “viral” challenge for future research in scleroderma. Autoimmunity Reviews 20:10, pages 102899.
Crossref
Hao Ying, Mohsen Ebrahimi, Mona Keivan, Seyed Esmaeil Khoshnam, Sarvenaz Salahi & Maryam Farzaneh. (2021) miRNAs; a novel strategy for the treatment of COVID‐19. Cell Biology International 45:10, pages 2045-2053.
Crossref
Dominika Dęborska-Materkowska & Dorota Kamińska. (2021) The Immunology of SARS-CoV-2 Infection and Vaccines in Solid Organ Transplant Recipients. Viruses 13:9, pages 1879.
Crossref
Pravas Kumar Baral, Jiang Yin & Michael N.G. James. (2021) Treatment and prevention strategies for the COVID 19 pandemic: A review of immunotherapeutic approaches for neutralizing SARS-CoV-2. International Journal of Biological Macromolecules 186, pages 490-500.
Crossref
Johan Jakobsson, Ian Cotgreave, Maria Furberg, Niklas Arnberg & Michael Svensson. (2021) Potential Physiological and Cellular Mechanisms of Exercise That Decrease the Risk of Severe Complications and Mortality Following SARS-CoV-2 Infection. Sports 9:9, pages 121.
Crossref
Balamurugan Shanmugaraj, Konlavat Siriwattananon, Ashwini Malla & Waranyoo Phoolcharoen. (2021) Potential for Developing Plant-Derived Candidate Vaccines and Biologics against Emerging Coronavirus Infections. Pathogens 10:8, pages 1051.
Crossref
Qinzhi Yang, Fang Lin, Yanan Wang, Min Zeng & Mao Luo. (2021) Long Noncoding RNAs as Emerging Regulators of COVID-19. Frontiers in Immunology 12.
Crossref
Milad Haghani & Pegah Varamini. (2021) Temporal evolution, most influential studies and sleeping beauties of the coronavirus literature. Scientometrics 126:8, pages 7005-7050.
Crossref
Jijing Shi, Jianglin Zhou, Xiaochang Zhang, Wei Hu, Jin-Fang Zhao, Shengqi Wang, Fu-Sheng Wang & Ji-Yuan Zhang. (2021) Single-Cell Transcriptomic Profiling of MAIT Cells in Patients With COVID-19. Frontiers in Immunology 12.
Crossref
Nathalie Chazal. (2021) Coronavirus, the King Who Wanted More Than a Crown: From Common to the Highly Pathogenic SARS-CoV-2, Is the Key in the Accessory Genes?. Frontiers in Microbiology 12.
Crossref
Fareeha Saadi, Debnath Pal & Jayasri Das Sarma. (2021) Spike Glycoprotein Is Central to Coronavirus Pathogenesis-Parallel Between m-CoV and SARS-CoV-2. Annals of Neurosciences 28:3-4, pages 201-218.
Crossref
Wei Fu, Chi Chen, Xin‐Lin Chen, Kun Wang, Peiyuan Zuo, Yuwei Liu, Meng Zhang, Xiaofang Zhao, Songpu Xie, Hao Zhang, Yan Geng & Chengyun Liu. (2021) A U‐shaped association between baseline neutrophil count and COVID‐19‐related mortality: A retrospective cohort study. Journal of Medical Virology 93:7, pages 4265-4272.
Crossref
Giulia Sita, Agnese Graziosi, Patrizia Hrelia & Fabiana Morroni. (2021) NLRP3 and Infections: β-Amyloid in Inflammasome beyond Neurodegeneration. International Journal of Molecular Sciences 22:13, pages 6984.
Crossref
Hana. M. A. Fakhoury, Peter R. Kvietys, Ismail Shakir, Hashim Shams, William B. Grant & Khaled Alkattan. (2021) Lung-Centric Inflammation of COVID-19: Potential Modulation by Vitamin D. Nutrients 13:7, pages 2216.
Crossref
Maloyjo Joyraj Bhattacharjee, Jinn-Jy Lin, Chih-Yao Chang, Yu-Ting Chiou, Tian-Neng Li, Chia-Wei Tai, Tz-Fan Shiu, Chi-An Chen, Chia-Yi Chou, Paromita Chakraborty, Yan Yuan Tseng, Lily Hui-Ching Wang & Wen-Hsiung Li. (2021) Identifying Primate ACE2 Variants That Confer Resistance to SARS-CoV-2. Molecular Biology and Evolution 38:7, pages 2715-2731.
Crossref
Amirhesam Babajani, Pooya Hosseini-Monfared, Samin Abbaspour, Elham Jamshidi & Hassan Niknejad. (2021) Targeted Mitochondrial Therapy With Over-Expressed MAVS Protein From Mesenchymal Stem Cells: A New Therapeutic Approach for COVID-19. Frontiers in Cell and Developmental Biology 9.
Crossref
Thomas Kehrer, Adolfo García-Sastre & Lisa Miorin. (2021) Control of Innate Immune Activation by Severe Acute Respiratory Syndrome Coronavirus 2 and Other Coronaviruses. Journal of Interferon & Cytokine Research 41:6, pages 205-219.
Crossref
Ahmet Özer Şehirli, Umut Aksoy, Revan Birke Koca-Ünsal & Serkan Sayıner. (2021) Role of NLRP3 inflammasome in COVID-19 and periodontitis: Possible protective effect of melatonin. Medical Hypotheses 151, pages 110588.
Crossref
Ramin Lotfi, Rasoul Nasiri Kalmarzi & Seyed Askar Roghani. (2021) A review on the immune responses against novel emerging coronavirus (SARS-CoV-2). Immunologic Research 69:3, pages 213-224.
Crossref
Arthur E. Frankel, Wai C. Yip, Eknath Naik & Hans C. Hasselbalch. (2021) Response to pegylated interferon in a COVID‐19 positive male with metastatic jejunal neuroendocrine tumor treated with everolimus. Clinical Case Reports 9:6.
Crossref
А.В. Адров, А.В. Бахаева & М.А. Тужиева. (2021) ОЦЕНКА СОСТОЯНИЯ СОСУДИСТО- ТРОМБОЦИТАРНОГО ГЕМОСТАЗА У ПАЦИЕНТОВ С COVID-19 (Обзор литературы). Вестник медицинского института:1/19, pages 111-115.
Crossref
Yiting Lin, Yiqun Wu, Ping Zhong, Bingbo Hou, Jielan Liu, Yingying Chen & Jiajun Liu. (2021) A clinical staging proposal of the disease course over time in non-severe patients with coronavirus disease 2019. Scientific Reports 11:1.
Crossref
Joshuan J. Barboza, Diego Chambergo-Michilot, Mariana Velasquez-Sotomayor, Christian Silva-Rengifo, Carlos Diaz-Arocutipa, Jose Caballero-Alvarado, Franko O. Garcia-Solorzano, Christoper A. Alarcon-Ruiz, Leonardo Albitres-Flores, German Malaga, Patricia Schlagenhauf & Alfonso J. Rodriguez-Morales. (2021) Assessment and management of asymptomatic COVID-19 infection: A systematic review. Travel Medicine and Infectious Disease 41, pages 102058.
Crossref
M. Mamtani, A.M. Athavale, M. Abraham, J. Vernik, A.R. Amarah, J.P. Ruiz, A.J. Joshi, M. Itteera, S.D. Zhukovski, R.P. Madaiah, B.C. White, P. Hart & H. Kulkarni. (2021) Association of hyperglycaemia with hospital mortality in nondiabetic COVID-19 patients: A cohort study. Diabetes & Metabolism 47:3, pages 101254.
Crossref
Irene A. Stafford, Jacqueline G. Parchem & Baha M. Sibai. (2021) The coronavirus disease 2019 vaccine in pregnancy: risks, benefits, and recommendations. American Journal of Obstetrics and Gynecology 224:5, pages 484-495.
Crossref
Youssef A. Attia, Mohamed T. El-Saadony, Ayman A. Swelum, Shaza Y.A. Qattan, Adel D. Al-qurashi, Khalid A. Asiry, Manal E. Shafi, Ahmed R. Elbestawy, Ahmed R. Gado, Asmaa F. Khafaga, Elsayed O.S. Hussein, Hani Ba-Awadh, Ruchi Tiwari, Kuldeep Dhama, Bakr Alhussaini, Salem R. Alyileili, Khaled A. El-Tarabily & Mohamed E. Abd El-Hack. (2021) COVID-19: pathogenesis, advances in treatment and vaccine development and environmental impact—an updated review. Environmental Science and Pollution Research 28:18, pages 22241-22264.
Crossref
Shiyu Yin, Ming Huang, Dengju Li & Ning Tang. (2020) Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2. Journal of Thrombosis and Thrombolysis 51:4, pages 1107-1110.
Crossref
Ahmet Cizmecioglu, Hilal Akay Cizmecioglu, Mevlut Hakan Goktepe, Ayca Emsen, Celalettin Korkmaz, Fatma Esenkaya Tasbent, Fatma Colkesen & Hasibe Artac. (2021) Apoptosis‐induced T‐cell lymphopenia is related to COVID‐19 severity. Journal of Medical Virology 93:5, pages 2867-2874.
Crossref
Chien-An A. Hu, Isabella Murphy, Stefan Klimaj, Jennifer Reece & Hitendra S. Chand. (2021) SARS-CoV-2, Inflammatory Apoptosis, and Cytokine Storm Syndrome. The Open COVID Journal 1:1, pages 22-31.
Crossref
Mar Pacheco-Herrero, Luis O. Soto-Rojas, Charles R. Harrington, Yazmin M. Flores-Martinez, Marcos M. Villegas-Rojas, Alfredo M. León-Aguilar, Paola A. Martínez-Gómez, B. Berenice Campa-Córdoba, Ricardo Apátiga-Pérez, Carolin N. Corniel-Taveras, Jesabelle de J. Dominguez-García, Víctor Manuel Blanco-Alvarez & José Luna-Muñoz. (2021) Elucidating the Neuropathologic Mechanisms of SARS-CoV-2 Infection. Frontiers in Neurology 12.
Crossref
Leila Mohamed Khosroshahi, Mohsen Rokni, Tahmineh Mokhtari & Farshid Noorbakhsh. (2021) Immunology, immunopathogenesis and immunotherapeutics of COVID-19; an overview. International Immunopharmacology 93, pages 107364.
Crossref
Balasubramanian Ganesh, Thangarasu Rajakumar, Mathiyazhakan Malathi, Natesan Manikandan, Jaganathasamy Nagaraj, Aridoss Santhakumar, Arumugam Elangovan & Yashpal Singh Malik. (2021) Epidemiology and pathobiology of SARS-CoV-2 (COVID-19) in comparison with SARS, MERS: An updated overview of current knowledge and future perspectives. Clinical Epidemiology and Global Health 10, pages 100694.
Crossref
Arthur E. Frankel, Renuka Reddy, Kayla R. DeSuza, Khaled Deeb, Aaron F. Carlin, Davey Smith, Yushuang Xie, Eknath Naik, Richard T. Silver & Hans C. Hasselbalch. (2021) Response to pegylated interferon in a COVID‐19–positive elderly woman with primary myelofibrosis treated with ruxolitinib. Clinical Case Reports 9:4, pages 2228-2235.
Crossref
Leila Mohamed Khosroshahi & Nima Rezaei. (2020) Dysregulation of the immune response in coronavirus disease 2019. Cell Biology International 45:4, pages 702-707.
Crossref
Athanasios Damialis, Stefanie GillesMikhail Sofiev, Viktoria SofievaFranziska KolekDaniela BayrMaria P. Plaza, Vivien Leier-WirtzSigrid KaschubaLewis H. Ziska, Leonard Bielory, László Makra, Maria del Mar Trigo, Claudia Traidl-HoffmannGilles Oliver, Nhan Pham-Thi, M. Thibaudon, Arturo H. Arino, J. Belmonte, Patricia Cervigon Morales, Concepcion de Linares, Delia Fernández, Santiago Fernandez-Rodriguez, Antonia Gabaldon Arguisuelas, Carmen Galan, Monica González-Alonso, Beatriz Lara, José María Moreno Grau, José Oteros, Rosa Pérez-Badia, Anabel Pérez-de-Zabalza, Antonio Picornell, Marta Recio, Estrella Robles, Alberto Rodríguez-Fernández, Javier F. Rodríguez-Rajo, Jesús Rojo, Luis Ruiz Valenzuela, Karl-Christian Bergmann, Barbora Werchan, Matthias Werchan, Jeroen T.M. Buters, Maximilian Bastl, Susanne Dunker, Thomas Hornick, Nestor González Roldán, Stefan Gilge, B. Clot, Stanley Finemann, Linda B. Ford, Robert Anthony Gomez, Sanjay Kamboj, Wayne Wilhelm, Paul J. Beggs, Pamela Burton, Janet M Davies, Simon Haberle, Constance Helen Katelaris, Ben Keaney, Andelija Milic, Victoria Miller, Shanice van Haeften, Maira Bonini, Anna Bordin, Valentina Ceriotti, Fabiana Cristofolini, Antonella Cristofori, Elena Gottardini, Guido Marcer, Paolo Marraccini, Paolo Mascagni, Antonio Meriggi, Loretta Pace, Alberto Pini, Maria Cristina Tacca, Nicolas Bruffaerts, Lucie Hoebeke, Beverley Adams-Groom, Catherine Helen Pashley, Jack Satchwell, C. A. Skjøth, Fiona A. Symon, Celia Maria Miguel Antunes, Elsa Caeiro, Irene Gomes Câmara Camacho, Ana Cristina Rodrigues Costa, Ricardo João Ratola Capela Deus, Manuel Branco Ferreira, Joao Almeida Lopes Fonseca, Ana Catarina Galveias Jorge, Helena Ribeiro, Beatriz Tavares, Łukasz Grewling, Agnieszka Grinn-Gofroń, Dariusz Jurkiewicz, Ewa Kalinowska, Agnieszka A Lipiec, Dorota Myszkowska, Krystyna Piotrowska-Weryszko, Malgorzata Puc, Anna Agnieszka Rapiejko, Piotr Rapiejko, Elżbieta Weryszko-Chmielewska, Monika Ziemianin, Dilys Berman, Werner Hoek, Ahmed Ismail Manjra, Jonathan Peter, Å. Dahl, Agneta Ekebom, Barbara Stjepanovic, Ana Večenaj, S. Celenk, Ozlem Goksel, Tuncay Goksel, Aykut Guvensen, Nur Munevver Pinar, Cansin Sackesen, Aydar Acar Sahin, Ulas Uguz, Duygu Yazici, Dóra Kajitor-Apatini, Donát Magyar, Tamás Szigeti, Branko Sikoparija, Andreja Kofol Seliger, Anja Simčič, Jae-Won Oh, Athanasios Charalampopoulos, D. Vokou, K. Rasmussen, Laura Beatriz Barrionuevo, German Dario Ramon, Letty A. de Weger, Mieke M.J.F. Koenders, Arnold J.H. van Vliet, Jozef Dušička, Janka Lafférsová, Jana Ščevková, O. Rybníček, Frances Coates, Dawn Jurgens, Ingrida Šaulienė, Elena Severova, V. Rodinkova, Mykyta Bortnyk, Olena Palamarchuk, Maryna Yasniuk, Maria Louna-Korteniemi, Sanna Pätsi, Annika Saarto, Linnea Toiviainen, Olga Sozinova & Peng Jia. (2021) Higher airborne pollen concentrations correlated with increased SARS-CoV-2 infection rates, as evidenced from 31 countries across the globe. Proceedings of the National Academy of Sciences 118:12.
Crossref
Corrado Pelaia, Cecilia Calabrese, Eugenio Garofalo, Andrea Bruni, Alessandro Vatrella & Girolamo Pelaia. (2021) Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence. International Journal of Molecular Sciences 22:6, pages 3059.
Crossref
Komudi Singh, Yun-Ching Chen, Shahin Hassanzadeh, Kim Han, Jennifer T. Judy, Fayaz Seifuddin, Ilker Tunc, Michael N. Sack & Mehdi Pirooznia. (2021) Network Analysis and Transcriptome Profiling Identify Autophagic and Mitochondrial Dysfunctions in SARS-CoV-2 Infection. Frontiers in Genetics 12.
Crossref
Volker Schirrmacher. (2021) Less Can Be More: The Hormesis Theory of Stress Adaptation in the Global Biosphere and Its Implications. Biomedicines 9:3, pages 293.
Crossref
Manna Zhang, Lin Li, Ma Luo & Binhua Liang. (2021) Genomic characterization and evolution of SARS-CoV-2 of a Canadian population. PLOS ONE 16:3, pages e0247799.
Crossref
Morteza Izadi, Luca Cegolon, Mohammad Javanbakht, Ali Sarafzadeh, Hassan Abolghasemi, Gholamhossein Alishiri, Shi Zhao, Behzad Einollahi, Mandana Kashaki, Nematollah Jonaidi-Jafari, Mosa Asadi, Ramezan Jafari, Saeid Fathi, Hassan Nikoueinejad, Mehrdad Ebrahimi, Sina Imanizadeh & Amir Hosein Ghazale. (2021) Ozone therapy for the treatment of COVID-19 pneumonia: A scoping review. International Immunopharmacology 92, pages 107307.
Crossref
Mohsen Ahmadi, Abbas Sharifi & Sarv Khalili. (2020) Presentation of a developed sub-epidemic model for estimation of the COVID-19 pandemic and assessment of travel-related risks in Iran. Environmental Science and Pollution Research 28:12, pages 14521-14529.
Crossref
Nima Hemmat, Zahra Asadzadeh, Noora Karim Ahangar, Hajar Alemohammad, Basira Najafzadeh, Afshin Derakhshani, Amir Baghbanzadeh, Hossein Bannazadeh Baghi, Darya Javadrashid, Souzan Najafi, Meriadeg Ar Gouilh & Behzad Baradaran. (2021) The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV. Archives of Virology 166:3, pages 675-696.
Crossref
Abdallah Barjas Qaswal, Aiman Suleiman, Hasan Guzu, Taima’a Harb & Bashir Atiyat. (2021) The Potential Role of Lithium as an Antiviral Agent against SARS-CoV-2 via Membrane Depolarization: Review and Hypothesis. Scientia Pharmaceutica 89:1, pages 11.
Crossref
Hayden D. Hedman, Eric Krawczyk, Yosra A. Helmy, Lixin Zhang & Csaba Varga. (2021) Host Diversity and Potential Transmission Pathways of SARS-CoV-2 at the Human-Animal Interface. Pathogens 10:2, pages 180.
Crossref
Agatha Treveil, Balazs Bohar, Padhmanand Sudhakar, Lejla Gul, Luca Csabai, Marton Olbei, Martina Poletti, Matthew Madgwick, Tahila Andrighetti, Isabelle Hautefort, Dezso Modos & Tamas Korcsmaros. (2021) ViralLink: An integrated workflow to investigate the effect of SARS-CoV-2 on intracellular signalling and regulatory pathways. PLOS Computational Biology 17:2, pages e1008685.
Crossref
S. Al‐Sarraj, C. Troakes, B. Hanley, M. Osborn, M. P. Richardson, M. Hotopf, E. Bullmore & I. P. Everall. (2020) Invited Review: The spectrum of neuropathology in COVID‐19. Neuropathology and Applied Neurobiology 47:1, pages 3-16.
Crossref
Ashkan Bagheri, Seyed Mohammad Iman Moezzi, Pouria Mosaddeghi, Sadra Nadimi Parashkouhi, Seyed Mostafa Fazel Hoseini, Fatemeh Badakhshan & Manica Negahdaripour. (2021) Interferon-inducer antivirals: Potential candidates to combat COVID-19. International Immunopharmacology 91, pages 107245.
Crossref
Md Abdul Alim Al-Bari, Showna Hossain & Md Kudrat-E Zahan. (2021) Exploration of sex-specific and age-dependent COVID-19 fatality rate in Bangladesh population. World Journal of Radiology 13:1, pages 1-18.
Crossref
Nicholas A. Wong & Milton H. SaierJr.Jr.. (2021) The SARS-Coronavirus Infection Cycle: A Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis. International Journal of Molecular Sciences 22:3, pages 1308.
Crossref
Md. Abdullah-Al-Kamran Khan & Abul Bashar Mir Md. Khademul Islam. (2021) SARS-CoV-2 Proteins Exploit Host’s Genetic and Epigenetic Mediators for the Annexation of Key Host Signaling Pathways. Frontiers in Molecular Biosciences 7.
Crossref
Abdulaziz Alamri, Derek Fisk, Deepak Upreti & Sam K. P. Kung. (2021) A Missing Link: Engagements of Dendritic Cells in the Pathogenesis of SARS-CoV-2 Infections. International Journal of Molecular Sciences 22:3, pages 1118.
Crossref
Tâmara Taynah Medeiros da Silva, Naryllenne Maciel de Araújo, Sabrina Daiane Gurgel Sarmento, Grayce Louyse Tinoco de Castro, Daniele Vieira Dantas & Rodrigo Assis Neves Dantas. (2021) IMPACT OF COVID-19 IN PATIENTS WITH CANCER: A SCOPING REVIEW. Texto & Contexto - Enfermagem 30.
Crossref
Gabriela Athziri Sánchez-Zuno, Mónica Guadalupe Matuz-Flores, Guillermo González-Estevez, Ferdinando Nicoletti, Francisco Javier Turrubiates-Hernández, Katia Mangano & José Francisco Muñoz-Valle. (2021) A review: Antibody-dependent enhancement in COVID-19: The not so friendly side of antibodies. International Journal of Immunopathology and Pharmacology 35, pages 205873842110501.
Crossref
Linda Bui, Zahra Zhu, Stephanie Hawkins, Alonso Cortez-Resendiz & Alfredo Bellon. (2021) Vitamin D regulation of the immune system and its implications for COVID-19: A mini review. SAGE Open Medicine 9, pages 205031212110140.
Crossref
Amit Druyan, Merav Lidar, Michal Brodavka, Itzchak Levy, Aviv Barzilai & Felix Pavlotsky. (2020) The risk for severe COVID 19 in patients with autoimmune and/or inflammatory diseases: First wave lessons . Dermatologic Therapy 34:1.
Crossref
Kiandokht Keyhanian, Raffaella Pizzolato Umeton, Babak Mohit, Vahid Davoudi, Fatemeh Hajighasemi & Mehdi Ghasemi. (2021) SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation. Journal of Neuroimmunology 350, pages 577436.
Crossref
Yiyin Chen, Sabra L. Klein, Brian T. Garibaldi, Huifen Li, Cunjin Wu, Nicole M. Osevala, Taisheng Li, Joseph B. Margolick, Graham Pawelec & Sean X. Leng. (2021) Aging in COVID-19: Vulnerability, immunity and intervention. Ageing Research Reviews 65, pages 101205.
Crossref
Murugesan Pooranachithra, Balasubramanian Chellammal Muthubharathi & Krishnaswamy Balamurugan. 2021. Coronavirus Therapeutics – Volume II. Coronavirus Therapeutics – Volume II 47 70 .
Artur Słomka, Gennaro Martucci, Giuseppe Maria Raffa, Pietro Giorgio Malvindi, Ewa Żekanowska, Roberto Lorusso, Piotr Suwalski & Mariusz Kowalewski. 2021. Coronavirus Therapeutics – Volume I. Coronavirus Therapeutics – Volume I 73 86 .
Insha Zahoor, Yue Li, Ramandeep Rattan & Shailendra Giri. 2021. Coronavirus Therapeutics – Volume I. Coronavirus Therapeutics – Volume I 211 222 .
Satarudra Prakash Singh, Manisha Pritam, Brijesh Pandey & Thakur Prasad Yadav. (2020) Microstructure, pathophysiology, and potential therapeutics of COVID‐19: A comprehensive review. Journal of Medical Virology 93:1, pages 275-299.
Crossref
Dan Zhang, Rui Guo, Lei Lei, Hongjuan Liu, Yawen Wang, Yili Wang, Hongbo Qian, Tongxin Dai, Tianxiao Zhang, Yanjun Lai, Jingya Wang, Zhiqiang Liu, Tianyan Chen, Aili He, Michael O’Dwyer & Jinsong Hu. (2021) Frontline Science: COVID-19 infection induces readily detectable morphologic and inflammation-related phenotypic changes in peripheral blood monocytes. Journal of Leukocyte Biology 109:1, pages 13-22.
Crossref
Deepika PurohitManisha SainiNisha PathakRavinder VermaDeepak KaushikPrashant KatiyarPawan JalwalParijat Pandey. (2020) COVID-19 ‘The Pandemic’: An Update on the Present Status of the Outbreak and Possible Treatment Options. Biomedical and Pharmacology Journal 13:4, pages 1791-1807.
Crossref
Gisela Canedo-Marroquín, Farides Saavedra, Catalina A. Andrade, Roslye V. Berrios, Linmar Rodríguez-Guilarte, María C. Opazo, Claudia A. Riedel & Alexis M. Kalergis. (2020) SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments. Frontiers in Immunology 11.
Crossref
Caterina Lonati, Stefano Gatti & Anna Catania. (2020) Activation of Melanocortin Receptors as a Potential Strategy to Reduce Local and Systemic Reactions Induced by Respiratory Viruses. Frontiers in Endocrinology 11.
Crossref
Qiang Wang, Tong Yang & Yang Wang. (2020) Reduced Treatment Sensitivity of SARS-CoV-2 After Multigenerational Human-to-Human Transmission. Frontiers in Physics 8.
Crossref
Hannah Jethwa, Ann Sullivan & Sonya Abraham. (2020) COVID-19 and Immunomodulatory Therapy — Can We Use Data from Previous Viral Pandemics?. The Journal of Rheumatology 47:12, pages 1734-1737.
Crossref
Aurora Jurado, María C. Martín, Cristina Abad-Molina, Antonio Orduña, Alba Martínez, Esther Ocaña, Oscar Yarce, Ana M. Navas, Antonio Trujillo, Luis Fernández, Esther Vergara, Beatriz Rodríguez, Bibiana Quirant, Eva Martínez-Cáceres, Manuel Hernández, Janire Perurena-Prieto, Juana Gil, Sergi Cantenys, Gema González-Martínez, María T. Martínez-Saavedra, Ricardo Rojo, Francisco M. Marco, Sergio Mora, Jesús Ontañón, Marcos López-Hoyos, Gonzalo Ocejo-Vinyals, Josefa Melero, Marta Aguilar, Delia Almeida, Silvia Medina, María C. Vegas, Yesenia Jiménez, Álvaro Prada, David Monzón, Francisco Boix, Vanesa Cunill & Juan Molina. (2020) COVID-19: age, Interleukin-6, C-reactive protein, and lymphocytes as key clues from a multicentre retrospective study. Immunity & Ageing 17:1.
Crossref
Jing Gao, Jun-Qiang Liu, Heng-Jun Wen, Hua Liu, Wei-Dong Hu, Xia Han, Chuan-Xing Li & Xiao-Jun Wang. (2020) The unsynchronized changes of CT image and nucleic acid detection in COVID-19: reports the two cases from Gansu, China. Respiratory Research 21:1.
Crossref
Violetta Opoka-Winiarska, Ewelina Grywalska & Jacek Roliński. (2020) Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases?. BMC Medicine 18:1.
Crossref
Sydney Kusumoputro, Shannon Tseng, Jonathan Tse, Christian Au, Candice Lau, Xiang Wang & Tian Xia. (2020) Potential nanoparticle applications for prevention, diagnosis, and treatment of COVID‐19. VIEW 1:4.
Crossref
Jonathan D. Geiger, Nabab Khan, Madhuvika Murugan & Detlev Boison. (2020) Possible Role of Adenosine in COVID-19 Pathogenesis and Therapeutic Opportunities. Frontiers in Pharmacology 11.
Crossref
Mohammad Bagher Majnooni, Sajad Fakhri, Yalda Shokoohinia, Narges Kiyani, Katrina Stage, Pantea Mohammadi, Mohammad Mehdi Gravandi, Mohammad Hosein Farzaei & Javier Echeverría. (2020) Phytochemicals: Potential Therapeutic Interventions Against Coronavirus-Associated Lung Injury. Frontiers in Pharmacology 11.
Crossref
Abul Bashar Mir Md. Khademul Islam & Md. Abdullah-Al-Kamran Khan. (2020) Lung transcriptome of a COVID-19 patient and systems biology predictions suggest impaired surfactant production which may be druggable by surfactant therapy. Scientific Reports 10:1.
Crossref
Anja Pišlar, Ana Mitrović, Jerica Sabotič, Urša Pečar Fonović, Milica Perišić Nanut, Tanja Jakoš, Emanuela Senjor & Janko Kos. (2020) The role of cysteine peptidases in coronavirus cell entry and replication: The therapeutic potential of cathepsin inhibitors. PLOS Pathogens 16:11, pages e1009013.
Crossref
Faleh Tamimi, Mohammad Abusamak, Bindu Akkanti, Zheng Chen, Seung‐Hee Yoo & Harry Karmouty‐Quintana. (2020) The case for chronotherapy in Covid‐19‐induced acute respiratory distress syndrome. British Journal of Pharmacology 177:21, pages 4845-4850.
Crossref
Steve P.H. Alexander, Jane F. Armstrong, Anthony P. Davenport, Jamie A. Davies, Elena Faccenda, Simon D. Harding, Francesca Levi‐Schaffer, Janet J. Maguire, Adam J. Pawson, Christopher Southan & Michael Spedding. (2020) A rational roadmap for SARS‐CoV‐2/COVID‐19 pharmacotherapeutic research and development: IUPHAR Review 29. British Journal of Pharmacology 177:21, pages 4942-4966.
Crossref
Lucrezia Spadera & Maria Spadera. (2020) Potential role of GcMAF in suppressing the severity of COVID-19-induced immune responses: Lesson learned from HIV. Medical Hypotheses 144, pages 110293.
Crossref
Daniel P. Cashman. (2020) Why the lower reported prevalence of asthma in patients diagnosed with COVID-19 validates repurposing EDTA solutions to prevent and manage treat COVID-19 disease. Medical Hypotheses 144, pages 110027.
Crossref
Mansab Ali Saleemi, Bilal Ahmad, Khaled Benchoula, Muhammad Sufyan Vohra, Hing Jian Mea, Pei Pei Chong, Navindra Kumari Palanisamy & Eng Hwa Wong. (2020) Emergence and molecular mechanisms of SARS-CoV-2 and HIV to target host cells and potential therapeutics. Infection, Genetics and Evolution 85, pages 104583.
Crossref
Lucio D’Anna, Joseph Kwan, Zoe Brown, Omid Halse, Sohaa Jamil, Dheeraj Kalladka, Marius Venter & Soma Banerjee. (2020) Characteristics and clinical course of Covid-19 patients admitted with acute stroke. Journal of Neurology 267:11, pages 3161-3165.
Crossref
Yongxia Zhou, Yineng Zheng, Quan Yang, Liangbo Hu, Juan Liao & Xiaoyan Li. (2020) Cohort study of chest CT and clinical changes in 29 patients with coronavirus disease 2019 (COVID-19). European Radiology 30:11, pages 6213-6220.
Crossref
Yan Zuo, Yunlei Liu, Qi Zhong, Ke Zhang, Yuanhong Xu & Zhongxin Wang. (2020) Lopinavir/ritonavir and interferon combination therapy may help shorten the duration of viral shedding in patients with COVID‐19: A retrospective study in two designated hospitals in Anhui, China. Journal of Medical Virology 92:11, pages 2666-2674.
Crossref
Tasnim H. Beacon, Ruey‐Chyi Su, Ted M. Lakowski, Geneviève P. Delcuve & James R. Davie. (2020) SARS‐CoV ‐2 multifaceted interaction with the human host. Part II : Innate immunity response, immunopathology, and epigenetics . IUBMB Life 72:11, pages 2331-2354.
Crossref
Ioana Roxana Bordea, Edit Xhajanka, Sebastian Candrea, Simion Bran, Florin Onișor, Alessio Danilo Inchingolo, Giuseppina Malcangi, Van H Pham, Angelo Michele Inchingolo, Antonio Scarano, Felice Lorusso, Ciro Gargiulo Isacco, Sergey K Aityan, Andrea Ballini, Gianna Dipalma & Francesco Inchingolo. (2020) Coronavirus (SARS-CoV-2) Pandemic: Future Challenges for Dental Practitioners. Microorganisms 8:11, pages 1704.
Crossref
Shweta Jaiswal, Mohit Kumar, Mandeep, Sunita, Yogendra Singh & Pratyoosh Shukla. (2020) Systems Biology Approaches for Therapeutics Development Against COVID-19. Frontiers in Cellular and Infection Microbiology 10.
Crossref
Sushmita Patra, Rout George Kerry, Ganesh Kumar Maurya, Bijayananda Panigrahi, Swati Kumari & Jyoti Ranjan Rout. (2020) Emerging Molecular Prospective of SARS-CoV-2: Feasible Nanotechnology Based Detection and Inhibition. Frontiers in Microbiology 11.
Crossref
O. A. Gromova & I. Yu. Torshin. (2020) Combined therapy for treatment of acute respiratory viral infections: analysis of combined complex AnviMax. Medical alphabet:21, pages 33-48.
Crossref
Natália Mulinari Turin de Oliveira, Isabella Fernandes da Silva Figueiredo, Liziane Cristine Malaquias da Silva, Karien Sauruk da Silva, Laryssa Regis Bueno, Bruna Barbosa da Luz, Cláudia Rita Corso, Maria Fernanda Paula Werner, Elizabeth Soares Fernandes & Daniele Maria-Ferreira. (2020) Tissue Proteases and Immune Responses: Influencing Factors of COVID-19 Severity and Mortality. Pathogens 9:10, pages 817.
Crossref
Chase W Nelson, Zachary Ardern, Tony L Goldberg, Chen Meng, Chen-Hao Kuo, Christina Ludwig, Sergios-Orestis Kolokotronis & Xinzhu Wei. (2020) Dynamically evolving novel overlapping gene as a factor in the SARS-CoV-2 pandemic. eLife 9.
Crossref
Antonietta Coppola, Anna Annunziata, Maurizia Lanza, Pasquale Imitazione & Giuseppe Fiorentino. (2020) Dyspnea in COVID-19: not just pneumonia. Minerva Pneumologica 59:3.
Crossref

Displaying 200 of 260 citing articles. Use the download link below to view the full list of citing articles.

Download full citations list